Evaluation and Management of New-Onset Exertional Dyspnea in a 15-Year-Old Runner
This 15-year-old runner requires objective diagnostic testing with cardiopulmonary exercise testing (CPET) to differentiate between exercise-induced bronchoconstriction (EIB), exercise-induced laryngeal obstruction (EILO), and other causes of exertional dyspnea—symptoms alone cannot establish the diagnosis.
Initial Diagnostic Approach
The absence of wheezing and chest tightness makes this presentation atypical for classic EIB, but does not rule it out. Begin with baseline spirometry before and after bronchodilator administration 1. If baseline spirometry is normal or near-normal (FEV₁ >80% predicted), proceed to provocative testing.
Key Diagnostic Testing Algorithm
For adolescent athletes with normal baseline spirometry:
Cardiopulmonary exercise testing (CPET) is the preferred initial test to reproduce symptoms and differentiate causes 1. This is particularly important in children and adolescents where exercise-induced dyspnea and hyperventilation often masquerade as asthma 1.
During exercise challenge, ensure heart rate reaches and sustains ≥95% of maximum in children and adolescents (higher than the 85% threshold for adults) 1. This intensity is critical for adequate provocation.
Perform spirometry immediately post-exercise: A ≥10% fall in FEV₁ confirms EIB 1.
Critical Differential Diagnoses to Consider
Exercise-induced laryngeal obstruction (EILO) is frequently misdiagnosed as asthma and should be strongly considered given the absence of typical asthmatic symptoms 1, 2. Key distinguishing features:
- EILO presents with inspiratory stridor, throat tightness, and dyspnea during peak exercise (not post-exercise like EIB) 3, 4
- Fails to respond to bronchodilator pretreatment 2, 3
- Requires continuous laryngoscopy during exercise for definitive diagnosis 1, 2
If CPET shows:
- Normal spirometry post-exercise but symptoms reproduced → Consider EILO and perform flexible laryngoscopy during exercise 1
- Hyperventilation pattern with low end-tidal CO₂ → Suggests dysfunctional breathing or exercise-induced hyperventilation 1
- Reduced peak VO₂ or abnormal cardiovascular response → Refer to cardiology 1
Common Pitfalls to Avoid
Do not treat empirically with bronchodilators without objective confirmation 5. Symptoms are neither sensitive nor specific for EIB—many athletes with respiratory symptoms during exercise do not have EIB, and conversely, some with EIB are asymptomatic 5.
Do not assume asthma based on a "therapeutic trial" of albuterol. Studies show 59.8% of patients ultimately diagnosed with EILO carried a prior asthma diagnosis and failed asthma treatment 3.
Look for inspiratory loop flattening on spirometry—present in 51% of EILO cases 3—but recognize this is not diagnostic and exercise laryngoscopy remains the gold standard.
Treatment Based on Confirmed Diagnosis
If EIB is Confirmed (≥10% FEV₁ drop post-exercise):
Prescribe a short-acting β₂-agonist (SABA) 15 minutes before exercise 5. This provides 2-4 hours of protection with strong evidence (26% reduction in maximum FEV₁ fall) 5.
Critical caveat: Use SABAs intermittently (less than 4 times per week). Daily use leads to tolerance with reduced duration and magnitude of protection 1, 5.
If symptoms persist despite pre-exercise SABA or if SABA is needed daily or more:
- Add daily inhaled corticosteroid (ICS) as first-line controller therapy 5. Allow 2-4 weeks for maximal effect 5.
- Alternative: Daily leukotriene receptor antagonist (LTRA), which provides protection in 50% of patients without tolerance 1, 5
- Do NOT use long-acting β₂-agonist (LABA) as monotherapy due to serious safety concerns 5
If EILO is Confirmed:
Refer to speech therapy for inspiratory muscle training and respiratory retraining as first-line treatment 4. Bronchodilators are ineffective for EILO 2, 3.
If Testing is Negative but Symptoms Persist:
Consider cardiac evaluation if breathlessness occurs with or without chest pain, particularly if CPET shows abnormal cardiovascular parameters 1.
Consider psychological evaluation if hyperventilation or anxiety patterns emerge during testing 1.
Practical Implementation
For this specific patient:
- Obtain baseline spirometry with bronchodilator
- Schedule CPET with post-exercise spirometry
- Have flexible laryngoscopy available if CPET reproduces symptoms without spirometric changes
- Measure end-tidal CO₂ and pH during symptom reproduction to identify hyperventilation patterns
The mean time from symptom onset to diagnosis in EILO is 1.6 years 3, emphasizing the importance of early, appropriate diagnostic testing rather than empiric treatment trials.